"Abnormal vascular network formation is a prerequisite for tumor growth. This phenomenon has prompted the development of therapeutic approaches targeting molecules involved in the formation of pathological blood vessels such as VEGF and its receptors VEGFR1, VEGFR2 and VEGFR3. Although some patients benefited from such an approach, the majority of patients had a poor outcome through a transient de ...